» Articles » PMID: 10390455

Randomised Controlled Trial of Long Term Efficacy of Captopril on Preservation of Kidney Function in Normotensive Patients with Insulin Dependent Diabetes and Microalbuminuria

Overview
Journal BMJ
Specialty General Medicine
Date 1999 Jul 3
PMID 10390455
Citations 39
Authors
Affiliations
Soon will be listed here.
Citing Articles

Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease.

Natale P, Palmer S, Navaneethan S, Craig J, Strippoli G Cochrane Database Syst Rev. 2024; 4:CD006257.

PMID: 38682786 PMC: 11057222. DOI: 10.1002/14651858.CD006257.pub2.


Acute and chronic kidney complications in children with type 1 diabetes mellitus.

Rivetti G, Hursh B, Del Giudice E, Marzuillo P Pediatr Nephrol. 2022; 38(5):1449-1458.

PMID: 35896816 PMC: 10060299. DOI: 10.1007/s00467-022-05689-w.


Cost Effectiveness of Dapagliflozin Added to Standard of Care for the Management of Diabetic Nephropathy in the USA.

Abegaz T, Diaby V, Sherbeny F, Ali A Clin Drug Investig. 2022; 42(6):501-511.

PMID: 35614298 DOI: 10.1007/s40261-022-01160-8.


Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the Renal Association UK guideline update 2021.

Banerjee D, Winocour P, Chowdhury T, De P, Wahba M, Montero R BMC Nephrol. 2022; 23(1):9.

PMID: 34979961 PMC: 8722287. DOI: 10.1186/s12882-021-02587-5.


Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.

Chung E, Ruospo M, Natale P, Bolignano D, Navaneethan S, Palmer S Cochrane Database Syst Rev. 2020; 10:CD007004.

PMID: 33107592 PMC: 8094274. DOI: 10.1002/14651858.CD007004.pub4.


References
1.
Laffel L, McGill J, Gans D . The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group. Am J Med. 1995; 99(5):497-504. DOI: 10.1016/s0002-9343(99)80226-5. View

2.
Mathiesen E, Feldt-Rasmussen B, Hommel E, Deckert T, Parving H . Stable glomerular filtration rate in normotensive IDDM patients with stable microalbuminuria. A 5-year prospective study. Diabetes Care. 1997; 20(3):286-9. DOI: 10.2337/diacare.20.3.286. View

3.
Mathiesen E, Hommel E, Giese J, Parving H . Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ. 1991; 303(6794):81-7. PMC: 1670656. DOI: 10.1136/bmj.303.6794.81. View

4.
Levey A, Gassman J, Hall P, WALKER W . Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. J Am Soc Nephrol. 1991; 1(9):1087-94. DOI: 10.1681/ASN.V191087. View

5.
Viberti G, Mogensen C, Groop L, Pauls J . Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group. JAMA. 1994; 271(4):275-9. View